-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
- Acadia Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 166M shares, a 0.68% increase year-over-year.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 164K shares, a 1.32% increase from 2022.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 162K shares, a 0.74% increase from 2021.
- Acadia Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 160K shares, a 2.01% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)